CRTX Market Cap History
Below is a table of the CRTX market cap history going back to 5/9/2019:

Date CRTX Market Cap

Also see: CRTX Shares Outstanding History
and CRTX YTD Return
CRTX Historical Market Cap:
+57.78% CAGR
CRTX Historical Market Cap: +57.78% CAGR

Mouse over chart for data details
Cortexyme is a clinical stage biopharmaceutical company focused on developing therapeutics based on data supporting a new theory of the cause of Alzheimer's disease and other degenerative disorders. Co. is targeting a specific, infectious pathogen tied to neurodegeneration and chronic inflammation in humans and animal models. Co.'s proprietary main drug candidate, COR388, is an orally administered, brain-penetrating small molecule gingipain inhibitor. We show 6 historical shares outstanding datapoints in our CRTX shares outstanding history coverage, used to compute CRTX market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing CRTX market cap history over the course of time is important for investors interested in comparing CRTX's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of CRTX versus a peer is one thing; comparing CRTX market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like CRTX can fluctuate over the course of history. With this page we aim to empower investors researching CRTX by allowing them to research the CRTX market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for CRTX:
CRTX SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Cortexyme (CRTX) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

CRVL Market Cap History
CRVS Market Cap History
CRY Market Cap History
CSBR Market Cap History
CSII Market Cap History
CSU Market Cap History
CTIC Market Cap History
CTLT Market Cap History
CTMX Market Cap History
CTRV Market Cap History
More Healthcare companies »


CRTX Market Cap History | | Copyright © 2017 - 2020, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.